Association between gut microbiota characteristics and therapeutic efficacy of multimodal combination therapy in hepatocellular carcinoma with portal vein tumor thrombus: a secondary analysis of a prospective phase II trial.

Lenvima (lenvatinib) - Eisai, Merck (MSD)

Kaitanni (cadonilimab) - Akesobio

http://www.ncbi.nlm.nih.gov/pubmed/42682622

Huabin Su; Hui Yan; Jiali Meng; Jie Ma; Jie Zeng; Jing Tang; Kai Hu; Li Liang; Lihua Yang; Minhui Liang; Muyun Li; Ning Mo; Xinwen Liang; Ye Li; Yufeng Lv; Zhiming Zeng

Sep 3, 2026